A case of neoadjuvant chemotherapy‐resistant muscle‐invasive bladder cancer that markedly responded to pembrolizumab before conversion radical cystectomy

A case of neoadjuvant chemotherapy‐resistant muscle‐invasive bladder cancer that markedly responded to pembrolizumab before conversion radical cystectomy

Introduction Recently, perioperative use of immune checkpoint inhibitors has improved the prognosis of muscle‐invasive bladder cancer. It is unclear whether radical cystectomy or systemic pembrolizumab is the optimal next treatment in patients with muscle‐invasive bladder cancer and progressive dise...

Full description

Bibliographic Details
Main Authors: Ichiro Yonese, Noboru Numao, Kentaro Inamura, Yusuke Yoneoka, Ryo Fujiwara, Yosuke Yasuda, Tomohiko Oguchi, Shinya Yamamoto, Takeshi Yuasa, Junji Yonese
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:IJU Case Reports
Subjects:
bladder cancer
conversion surgery
neoadjuvant chemotherapy
neoadjuvant immunotherapy
Online Access:https://doi.org/10.1002/iju5.12669

Internet

https://doi.org/10.1002/iju5.12669

Similar Items